The report of Global Piriformis Syndrome Market by Treatment (Medication, Physical Therapy, Osteopathic Manipulative Treatment (OMT)), Cause (Trauma, Spasms, Overuse injury, Others), End-User (Hospitals & Clinics, Diagnostic Centers, Others), and Region (North America, Europe, Middle East & Africa, South America, Asia Pacific) is expected to reach US$ XX Mn. by 2027, at a CAGR of 7.8% during a forecast period.
The MMR report analyzes various factors which have been driving the global piriformis syndrome market. The major factors responsible for influencing piriformis syndrome market areupsurge patient awareness level and high prevalence of piriformis syndrome. However, a challenge in the syndrome diagnosis between the patient pools is the major restraint factors for piriformis syndrome market.
North America will continue to dominate the piriformis syndrome market thanks to the growing healthcare expenditure, present well-established healthcare industry, expanding geriatric population. The high concentration of main hospitals in established economies of North America coupled with good repayment rates is driving the growth of the piriformis syndrome market.
Also, a large number of leading players in the U.S. is expected to contribute to the faster development of the piriformis syndrome market in the USA.Europe also plays important roles in piriformis syndrome market, with a market size of US$ XX Mn in 2018 and will be US$ XX Mn in 2026, with a CAGR of XX.13%. The piriformis syndrome market growth in EU is led by economies such as France and Germany.
In recent years, major players in the piriformis syndrome market have taken several strategic measures, like facility expansions and partnerships. For instant, Novartis Company would acquire Advanced Accelerator Applications in 2017; this is for US$3.9 Bn, paying US$41 per ordinary share & US$82 per American depositary share representing a 47% premium.
Key players operating in the Global Piriformis Syndrome Market are Sanofi S.A., Bayer AG, Novartis AG, AstraZeneca, Endo Pharmaceuticals, Teva Pharmaceuticals, Omron Healthcare, DePuy Synthes Companies, Miracle Stretch, LLC, Flex Pharma, Inc., Nidd valley medical, SEIRIN Corporation
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the Global Piriformis Syndrome Market. The report encompasses the market by different segments and regions, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics and future opportunities that might exist in the Global Piriformis Syndrome Market. The driving forces, as well as considerable restraints, have been explained in depth. In addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain Global Piriformis Syndrome Market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Piriformis Syndrome Market.”
https://www.maximizemarketresearch.com/market-report/global-piriformis-syndrome-market/70140/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, Vadgaon Bk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607195908